Follow
Vicente Soriano
Vicente Soriano
UNIR - Health Sciences School & Medical Center, Madrid, Spain
Verified email at unir.net - Homepage
Title
Cited by
Cited by
Year
Combination antiretroviral therapy and the risk of myocardial infarction
Data Collection on Adverse Events of Anti-HIV Drugs (DAD) Study Group
New England Journal of Medicine 349 (21), 1993-2003, 2003
20782003
Sexual activity without condoms and risk of HIV transmission in serodifferent couples when the HIV-positive partner is using suppressive antiretroviral therapy
AJ Rodger, V Cambiano, T Bruun, P Vernazza, S Collins, J Van Lunzen, ...
Jama 316 (2), 171-181, 2016
14152016
Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D: A: D study: a multi-cohort collaboration
D: A: D Study Group
The Lancet 371 (9622), 1417-1426, 2008
10852008
Sociodemographic and psychological variables influencing adherence to antiretroviral therapy
V Gordillo, J del Amo, V Soriano, J González-Lahoz
Aids 13 (13), 1763-1769, 1999
9751999
Raltegravir with optimized background therapy for resistant HIV-1 infection
RT Steigbigel, DA Cooper, PN Kumar, JE Eron, M Schechter, M Markowitz, ...
New England Journal of Medicine 359 (4), 339-354, 2008
8752008
Subgroup and resistance analyses of raltegravir for resistant HIV-1 infection
DA Cooper, RT Steigbigel, JM Gatell, JK Rockstroh, C Katlama, P Yeni, ...
New England Journal of Medicine 359 (4), 355-365, 2008
5852008
Prevalence of drug-resistant HIV-1 variants in untreated individuals in Europe: implications for clinical management
AMJ Wensing, DA Van De Vijver, G Angarano, B Åsjö, C Balotta, E Boeri, ...
The Journal of infectious diseases 192 (6), 958-966, 2005
5502005
Influence of hepatitis C virus infection on HIV-1 disease progression and response to highly active antiretroviral therapy
JK Rockstroh, A Mocroft, V Soriano, C Tural, MH Losso, A Horban, O Kirk, ...
The Journal of infectious diseases 192 (6), 992-1002, 2005
5362005
Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs
FL Altice, A Kamarulzaman, VV Soriano, M Schechter, GH Friedland
The Lancet 376 (9738), 367-387, 2010
5052010
Care of patients coinfected with HIV and hepatitis C virus: 2007 updated recommendations from the HCV–HIV International Panel
V Soriano, M Puoti, M Sulkowski, A Cargnel, Y Benhamou, M Peters, ...
Aids 21 (9), 1073-1089, 2007
4462007
Selection of hepatitis B virus polymerase mutations in HIV-coinfected patients treated with tenofovir
J Sheldon, N Camino, B Rodés, A Bartholomeusz, M Kuiper, F Tacke, ...
Antiviral therapy 10 (6), 727-734, 2005
3972005
Predictors of trend in CD4-positive T-cell count and mortality among HIV-1-infected individuals with virological failure to all three antiretroviral-drug classes
B Ledergerber, PLATO collaboration
The Lancet 364 (9428), 51-62, 2004
3882004
Care of patients with chronic hepatitis C and HIV co-infection: recommendations from the HIV–HCV International Panel
V Soriano, M Sulkowski, C Bergin, A Hatzakis, P Cacoub, C Katlama, ...
Aids 16 (6), 813-828, 2002
3872002
Impact of HIV-1 subtype and antiretroviral therapy on protease and reverse transcriptase genotype: results of a global collaboration
R Kantor, DA Katzenstein, B Efron, AP Carvalho, B Wynhoven, P Cane, ...
PLoS medicine 2 (4), e112, 2005
3772005
Risk factors for severe hepatic injury after introduction of highly active antiretroviral therapy.
M Núñez, R Lana, JL Mendoza, L Martín-Carbonero, V Soriano
Journal of acquired immune deficiency syndromes (1999) 27 (5), 426-431, 2001
3562001
Hepatocellular carcinoma in HIV-infected patients with chronic hepatitis C
J Garcı́a-Samaniego, M Rodrı́guez, J Berenguer, R Rodrı́guez-Rosado, ...
The American journal of gastroenterology 96 (1), 179-183, 2001
3402001
The state of hepatitis B and C in Europe: report from the hepatitis B and C summit conference
A Hatzakis, S Wait, J Bruix, M Buti, M Carballo, M Cavaleri, M Colombo, ...
Journal of viral hepatitis 18, 1-16, 2011
3392011
Safety and efficacy of dolutegravir in treatment-experienced subjects with raltegravir-resistant HIV type 1 infection: 24-week results of the VIKING Study
JJ Eron, B Clotet, J Durant, C Katlama, P Kumar, A Lazzarin, ...
The Journal of infectious diseases 207 (5), 740-748, 2013
3362013
Hepatocellular carcinoma in HIV-infected patients: epidemiological features, clinical presentation and outcome
M Puoti, R Bruno, V Soriano, F Donato, GB Gaeta, GP QUINZAN, ...
AIDS 18, 2285-93, 2004
330*2004
Kidney tubular abnormalities in the absence of impaired glomerular function in HIV patients treated with tenofovir
P Labarga, P Barreiro, L Martin-Carbonero, S Rodriguez-Novoa, C Solera, ...
Aids 23 (6), 689-696, 2009
3182009
The system can't perform the operation now. Try again later.
Articles 1–20